Martin Münchbach
InvestorManaging Partner at Pureos Bioventures
Zurich, Switzerland
Writes $100K – $5M checks · typically $1.5M
Contact· self-published, not guessed
Experience
- Pureos BioventuresManaging Partnercurrent2017 — presentZürich Area, Switzerland
- CitryllBoard Observercurrent2024 — presentOss, North Brabant, Netherlands
- Ypsomed AGBoard Membercurrent2019 — presentBurgdorf, Switzerland
- CASCINATIONMember Board of Directorscurrent2025 — presentBerne, Switzerland
- River Renal IncBoard Membercurrent2021 — presentNew York, Vereinigte Staaten von Amerika
- Alentis TherapeuticsBoard Observercurrent2019 — presentBasel, Kanton Basel-Stadt, Schweiz
- Ariceum TherapeuticsBoard Member2021 — 2025Munich, Bavaria, Germany
- Binx HealthBoard Member2011 — 2022Trowbridge, UK
- Tioga Pharmaceuticals, Inc.Board Member2005 — 2022Greater San Diego Area
- Lava Therapeutics B.V.Board Observer2020 — 2021Utrecht, Niederlande
- Bellevue Asset ManagementSenior Investment Manager Private Equity2004 — 2021Zürich Area, Switzerland
- Opsona TherapeuticsBoard Member2013 — 2019Dublin, Ireland
- Sonetik AGBoard Member2009 — 2019Zürich, Kanton Zürich, Schweiz
- Aleva Neurotherapeutics SABoard Member2016 — 2017Lausanne Area, Switzerland
- Radius Health, Inc.Board Member2007 — 2016Greater Boston Area
- Molecular Partners AGBoard Observer2007 — 2013Zurich, Switzerland
- Optimer PharmaceuticalsBoard Member2005 — 2008Greater San Diego Area
- Glycart Biotechnology AGBoard Observer2003 — 2005Zurich, Switzerland
- NMT New Medical Technologies/HBM Partners AG/BioMedinvestInvestment Manager1999 — 2004Basel/Zurich
- Axovan AGBoard Observer2000 — 2003Basel Area, Switzerland
Skills & more
Strategy12Pharmaceutical Industry26Biotechnology44Venture Capital51Medical Devices11Lifesciences31Technology Transfer19Commercialization22Clinical Development10R&D6Mergers & Acquisitions6Biopharmaceuticals10
+12 more
Start-upsLicensingCorporate DevelopmentVenture FinancingAngel InvestingOncologyPatentsDue DiligenceDrug DiscoveryMolecular BiologyIPOHardware DiagnosticsFrom Martin's professional profile.
Colleagues at Pureos Bioventures
Anne Grahl
Associate at Pureos Bioventures
Butrint Aliu
Analyst at Pureos Bioventures
Christian Altorfer
CFO/COO at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Veronica Gambillara Fonck
Partner at Pureos Bioventures
Frequently asked questions
- Who is Martin Münchbach?
- Managing Partner at Pureos Bioventures
- Where does Martin Münchbach work?
- Martin Münchbach is Managing Partner at Pureos Bioventures.
- What check size does Martin Münchbach write?
- Martin Münchbach typically writes checks of $100K – $5M.
- Where did Martin Münchbach go to school?
- Martin Münchbach studied at ETH Zürich (Dr. rer. nat. ETHZ, Proteinchemistry); ETH Zürich (MAS ETH MTEC, MAS ETH in Management); ETH Zürich (Dipl Natw. ETHZ, Biochemistry).
Same school
Also attended ETH Zürich225
Bastian HasslingerInvestor at Index VenturesSteve VassalloInvestor at Foundation CapitalHelge DaebelPartner, Head of Water at Emerald Technology Ventures AgMaurin DaiInvestment Manager, Physical AI & Robotics at Emerald Technology Ventures AgChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgMax HeftiInvestment Director - Energy at Emerald Technology Ventures Ag
+ 219 more
Also attended University of Tübingen29
Isabell GollmerInvestment Manager at Seed+SpeedPhilipp KobusManaging Partner at FraserPaul-Josef PattFounding Partner at eCAPITAL ENTREPRENEURIAL PARTNERSSimon SchminckeGeneral Partner at CreandumJana PetryInvestment Manager at UVC PartnersJan AdamsPartner at Apollo Health Ventures
+ 23 more
